● Recruiting

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

Condition: Heterozygous Familial Hypercholesterolemia · Sponsor: Nantes University Hospital

PhaseN/A

Planned participants200

Who can joinAll sexes, 35 Years to no upper limit

Healthy volunteersNo

About this study

The main goal of the STEATO-FH study is to determine the prevalence of liver steatosis within the Heterozygous Familial Hypercholesterolemia patient population.

This description comes directly from the study's public registry record.

Talk to the study team

Sarra SMATI · 02 53 48 27 19 · sarra.grangeon@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (3)

CHU angers	Angers, France	Not Yet Recruiting
CHU Nantes	Nantes, France	Recruiting
Rennes University Hospital	Rennes, France	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06634160